• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种致幻潜力降低的治疗性麦角酸二乙酰胺(LSD)类似物的分子设计。

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential.

作者信息

Tuck Jeremy R, Dunlap Lee E, Khatib Yara A, Hatzipantelis Cassandra J, Weiser Novak Sammy, Rahn Rachel M, Davis Alexis R, Mosswood Adam, Vernier Anna M M, Fenton Ethan M, Aarrestad Isak K, Tombari Robert J, Carter Samuel J, Deane Zachary, Wang Yuning, Sheridan Arlo, Gonzalez Monica A, Avanes Arabo A, Powell Noel A, Chytil Milan, Engel Sharon, Fettinger James C, Jenkins Amaya R, Carlezon William A, Nord Alex S, Kangas Brian D, Rasmussen Kurt, Liston Conor, Manor Uri, Olson David E

机构信息

Chemistry and Chemical Biology Graduate Program, University of California, Davis, CA 95616.

Institute for Psychedelics and Neurotherapeutics, University of California, Davis, CA 95616.

出版信息

Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2416106122. doi: 10.1073/pnas.2416106122. Epub 2025 Apr 14.

DOI:10.1073/pnas.2416106122
PMID:40228113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12037037/
Abstract

Decreased dendritic spine density in the cortex is a key pathological feature of neuropsychiatric diseases including depression, addiction, and schizophrenia (SCZ). Psychedelics possess a remarkable ability to promote cortical neuron growth and increase spine density; however, these compounds are contraindicated for patients with SCZ or a family history of psychosis. Here, we report the molecular design and de novo total synthesis of (+)-JRT, a structural analogue of lysergic acid diethylamide (LSD) with lower hallucinogenic potential and potent neuroplasticity-promoting properties. In addition to promoting spinogenesis in the cortex, (+)-JRT produces therapeutic effects in behavioral assays relevant to depression and cognition without exacerbating behavioral and gene expression signatures relevant to psychosis. This work underscores the potential of nonhallucinogenic psychoplastogens for treating diseases where the use of psychedelics presents significant safety concerns.

摘要

皮质中树突棘密度降低是包括抑郁症、成瘾和精神分裂症(SCZ)在内的神经精神疾病的关键病理特征。致幻剂具有促进皮质神经元生长和增加树突棘密度的显著能力;然而,这些化合物对患有SCZ或有精神病家族史的患者是禁忌的。在此,我们报告了(+)-JRT的分子设计和从头全合成,它是麦角酸二乙酰胺(LSD)的结构类似物,具有较低的致幻潜力和强大的促进神经可塑性的特性。除了促进皮质中的树突棘生成外,(+)-JRT在与抑郁症和认知相关的行为试验中产生治疗效果,而不会加剧与精神病相关的行为和基因表达特征。这项工作强调了非致幻性精神可塑性药物在治疗使用致幻剂存在重大安全问题的疾病方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/f4280b483f95/pnas.2416106122fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/24e9fcc34b4c/pnas.2416106122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/2df91b7c7284/pnas.2416106122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/aa3d8c594496/pnas.2416106122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/9be3ee6cb696/pnas.2416106122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/5a481f378968/pnas.2416106122fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/13bfece822d3/pnas.2416106122fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/f4280b483f95/pnas.2416106122fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/24e9fcc34b4c/pnas.2416106122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/2df91b7c7284/pnas.2416106122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/aa3d8c594496/pnas.2416106122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/9be3ee6cb696/pnas.2416106122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/5a481f378968/pnas.2416106122fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/13bfece822d3/pnas.2416106122fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fb/12037037/f4280b483f95/pnas.2416106122fig07.jpg

相似文献

1
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential.一种致幻潜力降低的治疗性麦角酸二乙酰胺(LSD)类似物的分子设计。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2416106122. doi: 10.1073/pnas.2416106122. Epub 2025 Apr 14.
2
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).麦角酰二乙酰胺的重现。第五部分:1-丁酰基-D-麦角酸二乙基酰胺(1B-LSD)的分析和行为特征。
Drug Test Anal. 2019 Aug;11(8):1122-1133. doi: 10.1002/dta.2613. Epub 2019 Jun 18.
3
Structure-based discovery of nonhallucinogenic psychedelic analogs.基于结构的非致幻迷幻剂类似物的发现。
Science. 2022 Jan 28;375(6579):403-411. doi: 10.1126/science.abl8615. Epub 2022 Jan 27.
4
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.一种具有治疗情绪障碍潜力的非致幻 LSD 类似物。
Cell Rep. 2023 Mar 28;42(3):112203. doi: 10.1016/j.celrep.2023.112203. Epub 2023 Mar 6.
5
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).LSD 类似物 N-乙基-N-环丙基麦角酰二乙胺(ECPLA)的药理学特征。
Psychopharmacology (Berl). 2019 Feb;236(2):799-808. doi: 10.1007/s00213-018-5055-9. Epub 2018 Oct 8.
6
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).麦角酰二乙胺的卷土重来。第六部分:1-环丙甲酰基-D-麦角酸二乙酰胺(1CP-LSD)的分析和行为特征。
Drug Test Anal. 2020 Jun;12(6):812-826. doi: 10.1002/dta.2789. Epub 2020 Apr 20.
7
Psychedelics without hallucinations?致幻剂无致幻作用?
Science. 2022 Jan 28;375(6579):370. doi: 10.1126/science.ada0540. Epub 2022 Jan 27.
8
Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).异构2,4 - 二甲基氮杂环丁烷的麦角酰胺类化合物确定了强效致幻剂N,N - 二乙基麦角酰胺(LSD)中二乙酰胺部分的结合取向。
J Med Chem. 2002 Sep 12;45(19):4344-9. doi: 10.1021/jm020153s.
9
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.反复给予麦角酸二乙基酰胺(LSD)可逆转应激引起的焦虑样行为、皮质突触发生缺陷和血清素能神经传递下降。
Neuropsychopharmacology. 2022 May;47(6):1188-1198. doi: 10.1038/s41386-022-01301-9. Epub 2022 Mar 17.
10
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).麦角酰胺类药物的回归。第一部分:1-丙酰基-d-麦角酸二乙酰胺(1P-LSD)的分析与行为特征
Drug Test Anal. 2016 Sep;8(9):891-902. doi: 10.1002/dta.1884. Epub 2015 Oct 12.

引用本文的文献

1
Psychedelics and the Serotonin Hypothesis of Eating Disorders.迷幻药与饮食失调的血清素假说
Brain Sci. 2025 Aug 21;15(8):893. doi: 10.3390/brainsci15080893.
2
The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation.精神可塑性原植物萝芙木碱可诱导神经可塑性,而无需近端立即早期基因激活。
Nat Neurosci. 2025 Aug 4. doi: 10.1038/s41593-025-02021-1.

本文引用的文献

1
Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder.涉及使用致幻剂的急诊科就诊与精神分裂症谱系障碍风险
JAMA Psychiatry. 2025 Feb 1;82(2):142-150. doi: 10.1001/jamapsychiatry.2024.3532.
2
Identification of 5-HT receptor signaling pathways associated with psychedelic potential.鉴定与致幻潜力相关的 5-HT 受体信号通路。
Nat Commun. 2023 Dec 15;14(1):8221. doi: 10.1038/s41467-023-44016-1.
3
Validation of a touchscreen probabilistic reward task for mice: A reverse-translated assay with cross-species continuity.
一种用于小鼠的触摸屏概率奖励任务的验证:具有跨物种连续性的反向翻译测定。
Cogn Affect Behav Neurosci. 2024 Apr;24(2):281-288. doi: 10.3758/s13415-023-01128-x. Epub 2023 Sep 28.
4
Early life stress in male mice blunts responsiveness in a translationally-relevant reward task.雄性小鼠的早期生活压力会削弱其在与翻译相关的奖励任务中的反应能力。
Neuropsychopharmacology. 2023 Nov;48(12):1752-1759. doi: 10.1038/s41386-023-01610-7. Epub 2023 May 31.
5
The synaptic hypothesis of schizophrenia version III: a master mechanism.精神分裂症的突触假说 III:主控机制
Mol Psychiatry. 2023 May;28(5):1843-1856. doi: 10.1038/s41380-023-02043-w. Epub 2023 Apr 11.
6
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.一种具有治疗情绪障碍潜力的非致幻 LSD 类似物。
Cell Rep. 2023 Mar 28;42(3):112203. doi: 10.1016/j.celrep.2023.112203. Epub 2023 Mar 6.
7
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.迷幻剂通过激活细胞内 5-HT2A 受体来促进神经可塑性。
Science. 2023 Feb 17;379(6633):700-706. doi: 10.1126/science.adf0435. Epub 2023 Feb 16.
8
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.5-HT2ARs 介导致幻色胺类药物的治疗行为效应。
ACS Chem Neurosci. 2023 Feb 1;14(3):351-358. doi: 10.1021/acschemneuro.2c00718. Epub 2023 Jan 11.
9
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.单次剂量裸盖菇素治疗难治性重度抑郁症发作。
N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443.
10
Bespoke library docking for 5-HT receptor agonists with antidepressant activity.具有抗抑郁活性的 5-HT 受体激动剂的定制文库对接。
Nature. 2022 Oct;610(7932):582-591. doi: 10.1038/s41586-022-05258-z. Epub 2022 Sep 28.